Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • The Last Word
  • Published:

Biotechnology in the Courtroom

Bio/Technology volume 10, page 1608 (1992)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Author notes

  1. Thomas H. Jenkins is a partner at Finnegan, Henderson, Farabow, Garrett & Dunner in Washington, D.C. This commentary is based on his remarks at “Biotechnology Patents: Problems and Prospects,” a symposium cosponsored by The American Type Culture Collection and Bio/Technology last summer.

    • Thomas H. Jenkins
Authors
  1. Thomas H. Jenkins
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jenkins, T. Biotechnology in the Courtroom. Nat Biotechnol 10, 1608 (1992). https://doi.org/10.1038/nbt1292-1608

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt1292-1608

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing